PLK1-IN-9
Product Specifications
CAS Number
893772-67-3
Target
PLK
Related Pathways
Cell Cycle/Checkpoint
Bioactivity
PLK1-IN-9 (Compound M2), a polo-like kinase 1 (PLK1) inhibitor, targets the PLK proteins modified with peptides 1010pT, cdc25c, and PBIP, exhibiting IC50 values of 1.6, 0.8, and 1.4 μM, respectively. This compound effectively inhibits the proliferation of various cancer cell lines including HeLa, HL60, SNU387/499, and HepG2, demonstrating cytotoxic effects and inducing apoptosis. Additionally, PLK1-IN-9 has been shown to suppress tumor growth in a HepG2 xenograft mouse model.
Smiles
O=C1N=C2C(=NC=3C=C(C=CC3N2C)C(F)(F)F)C(=O)N1
Molecular Formula
C12H7F3N4O2
Molecular Weight
296.2
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
364934 200 µL
ROS1 (C-Ros Oncogene 1, Receptor Tyrosine Kinase, MCF3, ROS, c-Ros-1, v-Ros Avian UR2 Sarcoma Virus Oncogene Homolog 1, Proto-oncogene tyrosine-protein kinase ROS, Receptor tyrosine kinase c-ros oncogene 1)
Sign In for Pricing
View Details orb2601964 100 µg
Integrin linked ILK Rabbit Polyclonal Antibody (APC)
Sign In for Pricing
View Details 